Because Lucentis is commonly injected to
treat diabetic macular edema (DME)-- a build - up of fluid in the center of the retina — the study permitted the use of Lucentis for DME in the laser group, if necessary.
VEGF inhibitors have been used for several years to
treat diabetic macular edema, a swelling of the retina that can occur as blood leaks around it.
Not exact matches
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to
treat vision loss from
diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost - effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.